🔥 Trending Cetirizine Recall: What You Need to Know About the Allergy Medication Recall

A nationwide recall has been issued for specific lots of Cetirizine Hydrochloride Tablets USP 5 mg due to potential cross-contamination with ranitidine ¹¹⁰. This voluntary recall was initiated by Unique Pharmaceutical Laboratories (a division of J. B. Chemicals & Pharmaceuticals Ltd.) and announced by the U.S. Food and Drug Administration (FDA) on July 21, 2026 ¹²⁸.

Details of the Recall

The core issue stems from the possibility that some cetirizine hydrochloride tablets may contain traces of ranitidine ³⁵. Ranitidine, formerly a popular antacid sold under the brand name Zantac, was itself subject to recalls due to the presence of a probable human carcinogen, N-Nitrosodimethylamine (NDMA) ³.

Affected Product and Manufacturer

• Product: Cetirizine Hydrochloride Tablets USP 5 mg ¹¹⁰
• Manufacturer: Unique Pharmaceutical Laboratories (A Div. of J. B. Chemicals & Pharmaceuticals Ltd.) ¹
• Retailer (Generic Version): This product is often sold as a generic version of Zyrtec ³.
• Packaging: The recalled tablets are sold in 100-count bottles ².

Reason for Recall

The primary reason for the recall is the potential for cross-contamination with ranitidine during the manufacturing process ⁵⁷. While the FDA notice specifically mentions "cross-contamination with another medication," other sources clarify this medication as ranitidine ⁵⁶.

Potential Health Risks

For most individuals, ingesting small amounts of ranitidine might not pose an immediate threat. However, for consumers with a known hypersensitivity or allergy to ranitidine or its ingredients, there is a reasonable probability of adverse reactions ⁴. These reactions could potentially be life-threatening ³⁷.

Symptoms that could indicate a severe allergic reaction to ranitidine include:

• Swelling of the face or throat ⁹
• Difficulty breathing or swallowing ⁹
• Hives ⁹
• Dizziness ⁹

Anyone experiencing these symptoms after taking the medication should seek immediate medical attention ⁹.

Identifying Recalled Products

Consumers can identify the recalled product by checking the name, manufacturer details, and lot number displayed on the bottle ². The FDA has specifically mentioned that four lots of Cetirizine Hydrochloride 5 mg are subject to this recall ⁶⁷¹⁰.

What Consumers Should Do

If you possess Cetirizine Hydrochloride Tablets USP 5 mg manufactured by Unique Pharmaceutical Laboratories, it is advised to:

1. Stop using the product: Discontinue use immediately ⁹.
2. Check lot numbers: Verify if your bottle belongs to one of the recalled lots ⁹. While specific lot numbers were not provided in the general announcements, they would typically be available on the manufacturer's or FDA's official recall notice.
3. Contact the manufacturer or retailer: For information on how to return the product or receive a refund ².
4. Seek medical advice: If you have concerns about your health or have experienced any adverse reactions, consult a healthcare professional ⁹.

This recall underscores the importance of vigilance in pharmaceutical manufacturing and the FDA's role in ensuring drug safety.